Vext Science, Inc.
VEXTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $27,247 | $35,380 | $24,994 | $69,723 |
| - Cash | $4,625 | $8,720 | $5,934 | $6,467 |
| + Debt | $39,517 | $38,597 | $38,153 | $14,102 |
| Enterprise Value | $62,140 | $65,257 | $57,213 | $77,358 |
| Revenue | $35,998 | $34,812 | $35,411 | $37,244 |
| % Growth | 3.4% | -1.7% | -4.9% | – |
| Gross Profit | $8,978 | $12,038 | $23,098 | $18,685 |
| % Margin | 24.9% | 34.6% | 65.2% | 50.2% |
| EBITDA | -$2,021 | $17,357 | $15,031 | $12,795 |
| % Margin | -5.6% | 49.9% | 42.4% | 34.4% |
| Net Income | -$22,435 | $4,398 | $10,919 | $4,987 |
| % Margin | -62.3% | 12.6% | 30.8% | 13.4% |
| EPS Diluted | -0.093 | 0.027 | 0.075 | 0.034 |
| % Growth | -448.7% | -64.5% | 122.5% | – |
| Operating Cash Flow | $3,289 | $4,425 | $5,923 | $11,681 |
| Capital Expenditures | -$1,465 | -$2,737 | -$8,860 | -$18,784 |
| Free Cash Flow | $1,823 | $1,688 | -$2,938 | -$7,102 |